iBio, Inc. (IBIO)
0.7823
+0.01
(+1.77%)
USD |
NASDAQ |
Nov 02, 16:00
0.7853
0.00 (0.00%)
After-Hours: 16:58
iBio Price : 0.7823 for Nov. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 0.81 | 0.8106 | 0.74 | 0.7687 | 214291.0 |
| Oct 29, 2026 | 0.819 | 0.83 | 0.7768 | 0.8136 | 248631.0 |
| Oct 28, 2026 | 0.77 | 0.808 | 0.7401 | 0.8042 | 281721.0 |
| Oct 27, 2026 | 0.7071 | 0.7739 | 0.69 | 0.7669 | 478170.0 |
| Oct 26, 2026 | 0.73 | 0.73 | 0.6859 | 0.707 | 509285.0 |
| Oct 23, 2026 | 0.77 | 0.784 | 0.7109 | 0.7178 | 655171.0 |
| Oct 22, 2026 | 0.84 | 0.8496 | 0.75 | 0.784 | 654787.0 |
| Oct 21, 2026 | 0.843 | 0.8798 | 0.84 | 0.84 | 518043.0 |
| Oct 20, 2026 | 0.7601 | 0.8914 | 0.7601 | 0.821 | 2.216M |
| Oct 19, 2026 | 0.759 | 0.7776 | 0.75 | 0.7601 | 355601.0 |
| Oct 16, 2026 | 0.784 | 0.7999 | 0.7601 | 0.7663 | 312701.0 |
| Oct 15, 2026 | 0.75 | 0.8208 | 0.75 | 0.7828 | 354728.0 |
| Oct 14, 2026 | 0.7754 | 0.81 | 0.7328 | 0.7808 | 1.440M |
| Oct 13, 2026 | 0.8977 | 0.8977 | 0.77 | 0.7818 | 1.351M |
| Oct 12, 2026 | 0.89 | 0.95 | 0.8849 | 0.9032 | 452152.0 |
| Oct 09, 2026 | 0.92 | 0.9698 | 0.8506 | 0.871 | 1.647M |
| Oct 08, 2026 | 1.00 | 1.000 | 0.9002 | 0.92 | 685124.0 |
| Oct 07, 2026 | 1.05 | 1.06 | 0.97 | 1.01 | 2.709M |
| Oct 06, 2026 | 1.12 | 1.15 | 1.02 | 1.05 | 1.210M |
| Oct 05, 2026 | 1.14 | 1.18 | 1.08 | 1.12 | 1.127M |
| Oct 02, 2026 | 1.12 | 1.15 | 1.065 | 1.125 | 534395.0 |
| Oct 01, 2026 | 1.18 | 1.210 | 1.10 | 1.11 | 341275.0 |
| Sep 30, 2026 | 1.19 | 1.22 | 1.17 | 1.18 | 229671.0 |
| Sep 29, 2026 | 1.195 | 1.195 | 1.16 | 1.17 | 236488.0 |
| Sep 28, 2026 | 1.19 | 1.19 | 1.15 | 1.17 | 297211.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.46 |
| Alnylam Pharmaceuticals, Inc. | 157.89 |
| Anika Therapeutics, Inc. | 19.36 |
| Savara, Inc. | 4.725 |
| Vericel Corp. | 40.54 |
Price Related Metrics
| PS Ratio | 640.34 |
| Price to Book Value | 0.5083 |
| Earnings Yield | -57.98% |
| Market Cap | 43.57M |